Clinical trialNCT05723198RecruitingPhase 3Interventional

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

SponsorEli Lilly and CompanyEnrollment595AlopeciaAreata AlopeciaHair DiseasesHypotrichosisPathological Conditions, AnatomicalSkin Diseases

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age. The study is divided into 4 periods, a 5-week Screening period, a 36-week Double-Blind Treatment Period, an approximately 2-year Long-term Extension (LTE) Period, and a 4-week Post-treatment Follow-up period. Some individuals may be eligible to receive treatment after completing the LTE, for a maximum of 180 weeks.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

127 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Derma Internacional Sa
Buenos Aires, Argentina
Maria Galimberti
Recruiting
Fundación Respirar
Buenos Aires, Argentina
Maria Fernandez
Recruiting
Psoriahue Medicina Interdisciplinaria
Buenos Aires, Argentina
Gabriel Alejandro Magarinos
Recruiting
Buenos Aires Skin
Ciudad Autonoma Buenos Aires, Argentina
Matias Turienzo
Recruiting
Instituto de Neumonología Y Dermatología
Ciudad Autonoma Buenos Aires, Argentina
Paula Luna
Recruiting
Hospital Universitario Austral
Pilar, Argentina
Carla Castro
Not, yet, recruiting
Centro Medico Privado de Reumatologia
SAN M. de Tucuman, Argentina
Completed
Hospital del Niño Jesus
San Miguel de Tucumán, Argentina
Maria Fiandrino
Recruiting

Australia

Skin and Cancer Foundation Australia - Darlinghurst Clinic
Darlinghurst, Australia
Completed
Sinclair Dermatology
Melbourne, Australia
Samantha Eisman
Recruiting
Institute for Skin, Health, and Immunity
Mitcham, Australia
John Su
Recruiting
Veracity Clinical Research Pty Ltd
Wooloongabba, Australia
Lynda Spelman
Recruiting

Canada

Dermatology Research Institute
Calgary, Canada
Vimal Prajapati
Recruiting
Skin Health
Cobourg, Canada
Melinda Gooderham
Recruiting
Lynderm Research Inc.
Markham, Canada
Charles Lynde
Recruiting
Dr. Chih-Ho Hong Medical Inc.
Surrey, Canada
Gurbir Dhadwal
Recruiting
Research Toronto
Toronto, Canada
Sameh Hanna
Recruiting
Wiseman Dermatology Research Inc.
Winnipeg, Canada
Marni Wiseman
Recruiting

France

Chru de Brest - Hôpital Morvan
Brest, France
Claire Abasq
Not, yet, recruiting
Ap-Hm Chu Timone - Pharmacie Secteur Essais Cliniques
Marseille, France
Stephanie Mallet
Recruiting
Centre Hospitalier Universitaire de Nantes - L' Hopital L'Hôtel-Dieu
Nantes, France
Sebastien Barbarot
Recruiting
Centre Hospitalier Universitaire de Nice - Hôpital L'Archet
Nice, France
Thierry Passeron
Recruiting
Centre de Sante Sabouraud
Paris, France
Pascal Reygagne
Recruiting
Hôpital Clocheville Chru-Tours Département Dermatologie
Tours, France
Annabel Maruani
Recruiting

Germany

Fachklinik Bad Bentheim
Bad Bentheim, Germany
Athanasios Tsianakas
Recruiting
Charite - Universitaetsmedizin Berlin - Campus Charite Mitte (ccm)
Berlin, Germany
Ulrike Blume-Peytavi
Recruiting
Universitätsklinikum Carl Gustav Carus
Dresden, Germany
Roland Aschoff
Recruiting
Klinikum Der Johann Wolfgang Goethe-Universität Frankfurt
Frankfurt am Main, Germany
Andreas Pinter
Recruiting
Kath. Kinderkrankenhaus Wilhelmstift
Hamburg, Germany
Peter Hoeger
Recruiting
Dermatologische Gemeinschaftspraxis Dres. Quist
Mainz, Germany
Sven Quist
Recruiting
Klinikum Rechts Der Isar Der Tu München
München, Germany
Christina Schnopp
Not, yet, recruiting
University of Muenster, Dept. of Dermatology, Central Study Coordination for Innovative Dermatology
Münster, Germany
Nina Magnolo
Recruiting

Hungary

Debreceni Egyetem Orvos-Es Egészsegtudomanyi Centrum
Debrecen, Hungary
Completed
Somogy Megyei Kaposi Mor Oktato Korhaz
Kaposvár, Hungary
Beata Fabos
Not, yet, recruiting
Pecsi Tudomanyegyetem
Pécs, Hungary
Adriana Csernus
Recruiting

Japan

Hamamatsu University Hospital
Hamamatsu, Japan
Taisuke Ito
Recruiting
Kurume University Hospital
Kurume, Japan
Yohei Natsuaki
Recruiting
Kyorin University Hospital
Mitaka, Japan
Misaki Kinoshita
Recruiting
Rifu Dermatology Allergy Clinic
Miyagi-gun, Japan
Masato Mizuashi
Recruiting
Niigata University Medical & Dental Hospital
Niigata, Japan
Ryota Hayashi
Recruiting

87 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Baricitinib →Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Feb 2023
Primary completion: 31 Mar 2028
Completion: 30 Sept 2033
Last update posted: 17 Jul 2026
Registered enrollment: 595
Registry id: NCT05723198

Cross-registrations

EU-CTR / CTIS (EudraCT)2022-502700-78-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.